Copyright
©The Author(s) 2021.
World J Clin Cases. Nov 26, 2021; 9(33): 10244-10248
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10244
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10244
Ref. | Hormone regimen | Dose | Duration |
Martin et al[12], 1988 | Post-operation, oral contraceptive | Ethinyl oestradiol 30 µg; levonorgestrel 150 µg | Start on the day of abortion, daily for 21 d |
Tang et al[13], 2002 | Post-operation, oral contraceptive | Ethinyl oestradiol 30 µg; levonorgestrel 150 µg | Start 1 d after the administration of misoprostol, daily for 21 d |
Liu et al[14], 2006 | Post-operation, estrogenic supplementation | Oestradiol valerate 1mg | Start 1 d after abortion, daily for 14-18 d |
Wang et al[15], 2011 | Post-operation, oestrogenic-progesterone sequential administration | Oestradiol valerate 2 mg; Medroxyprogesterone 10 mg | Oestradiol valerate, start 1 d after abortion, daily for 21 d; Medroxyprogesterone, daily for the last 5 d |
Farhi et al[16], 1993 | Post-operation, oestrogenic-progesterone sequential administration | Oestradiol valerate 2 mg; Norgestrel 0.5 mg | Oestradiol valerate, start 1 d after abortion, daily for 21 d; Norgestrel, daily for the last 10 d |
Luo et al[17], 2012 | Pre-operation, oestrogen supplementation | Oestradiol valerate 5 mg | Oestradiol valerate, daily for 3 d before abortion |
- Citation: Zhao P, Zhao Y, He J, Bai XX, Chen J. Subsequent placenta accreta after previous mifepristone-induced abortion: A case report. World J Clin Cases 2021; 9(33): 10244-10248
- URL: https://www.wjgnet.com/2307-8960/full/v9/i33/10244.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i33.10244